Latest Regulatory Compliance News

Page 97 of 156
Baby Bunting Group confirms its FY25 financial results align with prior guidance and analyst expectations, addressing ASX queries on disclosure timing amid notable share price movements.
Logan Eniac
Logan Eniac
21 Aug 2025
SkyCity Entertainment Group reports a 5% revenue decline in FY25 amid economic headwinds and elevated investments, announcing a $240 million equity raise to bolster its balance sheet ahead of the NZICC opening and online gaming launch.
Victor Sage
Victor Sage
21 Aug 2025
Medical Developments International Ltd reported an 18% increase in revenue to $39.1 million for FY25, returning to profitability with a net profit after tax of $0.1 million. The company advanced its Penthrox market expansion through regulatory approvals and new partnerships.
Ada Torres
Ada Torres
21 Aug 2025
IDT Australia Limited reported a strong 40.6% increase in revenue to $19.86 million for FY25, driven by growth in advanced therapies and contract disbursements. However, the company’s net loss widened to $8.06 million as it transitions from its ‘Rebuild Strategy’ to a new phase focused on sustainable profitability.
Victor Sage
Victor Sage
21 Aug 2025
EQT Holdings Limited reported record funds under management and a solid financial performance for FY25, successfully completing its three-year strategic integration program. The company’s margin recovery and dividend growth signal a confident outlook amid ongoing regulatory challenges.
Claire Turing
Claire Turing
21 Aug 2025
EQT Holdings Limited reported a robust FY25 with a 60% jump in net profit and record funds under management, while completing a major acquisition integration and raising dividends.
Claire Turing
Claire Turing
21 Aug 2025
Ridley Corporation Limited reported a solid FY25 with revenue up 3.1% to $1.3 billion and net profit after tax rising 8.7% to $43.3 million. The company declared a fully franked final dividend of 5.00 cents per share, signaling confidence in its diversified growth strategy.
Ada Torres
Ada Torres
21 Aug 2025
Telix Pharmaceuticals reported a robust 63% increase in revenue to $390.4 million for the first half of 2025, driven by strong Illuccix sales and the acquisition of RLS Radiopharmacies. Despite this growth, the company recorded a net loss of $2.3 million, reflecting increased investments and finance costs.
Ada Torres
Ada Torres
21 Aug 2025
Mount Ridley Mines Limited has announced a pro-rata entitlement offer to raise up to $596,842, accompanied by free attaching options, alongside a $234,000 placement aimed at funding key exploration projects and working capital.
Maxwell Dee
Maxwell Dee
21 Aug 2025
Heartland Group Holdings Limited reported an underlying NPAT of NZD 46.9 million for FY2025, meeting guidance, while setting ambitious growth and efficiency targets for FY2026.
Claire Turing
Claire Turing
21 Aug 2025
Kaili Resources Limited has resumed trading on the ASX following a suspension triggered by regulatory queries. The company’s prompt response to ASX concerns has cleared the way for its securities to re-enter the market.
Maxwell Dee
Maxwell Dee
20 Aug 2025
Kaili Resources has officially confirmed a change of control with Mr Jianzhong Yang now holding over 60% of shares, alongside a significant board reshuffle. The company remains focused on advancing its rare earth elements exploration in South Australia.
Maxwell Dee
Maxwell Dee
20 Aug 2025